Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

A recent study published in the Journal of Psychopharmacology has offered encouraging preliminary findings for individuals with severe obsessive-compulsive disorder who have not responded to standard ...

The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders.

The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), ...

The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders. But the drug does have ...

The total appointment time for each infusion ranges from four to six hours. Although Ocrevus has been proven effective in patients, the immune-suppressing therapy carries risks of side effects ...

Advert According to a shocking lawsuit which has since been filed by her family, she'd been consuming a considerable five-six grams of ketamine per day in the months prior, and was suffering several ...

“Despite extensive studies on IV ketamine infusions, there are gaps in understanding the most effective dosage ... Participants also reported less of the known side effects associated with intravenous ...

MADRS evaluations were conducted at baseline (day 0), 4 and 24 hours after each intravenous ketamine injection, and two weeks post-infusion (day 26). The inter-evaluator correlation coefficient was ...